newsfilter
← Latest News
ACCESS Newswire·

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. , a developer of a multi-faceted patent-pending drug delivery technology, received notice (the